Mezagitamab (Anti-CD38)
Mezagitamab (Anti-CD38) is a human, non-agonistic immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein ADP-ribosyl cyclase 1 (CD38) with potential immunomodulating and antineoplastic activities. MW : 144.44 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2819 |
| Sku # | A2819-1mg*5 |
| Pricing | 1mg*5, $970.00 |